1. Home
  2. BCYC vs ACCO Comparison

BCYC vs ACCO Comparison

Compare BCYC & ACCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • ACCO
  • Stock Information
  • Founded
  • BCYC 2009
  • ACCO 1893
  • Country
  • BCYC United Kingdom
  • ACCO United States
  • Employees
  • BCYC N/A
  • ACCO N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • ACCO Publishing
  • Sector
  • BCYC Health Care
  • ACCO Consumer Discretionary
  • Exchange
  • BCYC Nasdaq
  • ACCO Nasdaq
  • Market Cap
  • BCYC 620.7M
  • ACCO 487.6M
  • IPO Year
  • BCYC 2019
  • ACCO N/A
  • Fundamental
  • Price
  • BCYC $8.56
  • ACCO $4.19
  • Analyst Decision
  • BCYC Buy
  • ACCO Buy
  • Analyst Count
  • BCYC 8
  • ACCO 1
  • Target Price
  • BCYC $29.14
  • ACCO $7.00
  • AVG Volume (30 Days)
  • BCYC 331.4K
  • ACCO 984.6K
  • Earning Date
  • BCYC 05-01-2025
  • ACCO 05-01-2025
  • Dividend Yield
  • BCYC N/A
  • ACCO 7.15%
  • EPS Growth
  • BCYC N/A
  • ACCO N/A
  • EPS
  • BCYC N/A
  • ACCO N/A
  • Revenue
  • BCYC $35,275,000.00
  • ACCO $1,666,200,000.00
  • Revenue This Year
  • BCYC N/A
  • ACCO N/A
  • Revenue Next Year
  • BCYC $18.29
  • ACCO $1.07
  • P/E Ratio
  • BCYC N/A
  • ACCO N/A
  • Revenue Growth
  • BCYC 30.76
  • ACCO N/A
  • 52 Week Low
  • BCYC $8.20
  • ACCO $4.16
  • 52 Week High
  • BCYC $28.67
  • ACCO $6.44
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 29.39
  • ACCO 35.55
  • Support Level
  • BCYC $8.60
  • ACCO $4.33
  • Resistance Level
  • BCYC $9.69
  • ACCO $4.56
  • Average True Range (ATR)
  • BCYC 0.67
  • ACCO 0.16
  • MACD
  • BCYC 0.00
  • ACCO -0.01
  • Stochastic Oscillator
  • BCYC 6.05
  • ACCO 4.52

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About ACCO Acco Brands Corporation

ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through three segments: ACCO Brands North America, ACCO Brands EMEA, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. It offers its products under the AT-A-GLANCE, Five Star, GBC, Hilroy, Kensington, Quartet, Leitz, NOBO and other brands. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands North America segment.

Share on Social Networks: